Belgium/epidemiology; Breast Neoplasms/epidemiology; Female; Humans; Incidence; Life Style; Mass Screening; Risk Factors
Résumé :
[en] Breast cancer incidence in Belgium is on the top of European countries, with 9.697 new cases in 2008 and 106/100.000 women/year. The explanation of this high incidence in our country is probably the accumulation of risk factors (many of them are linked to lifestyle), and the impact of screening and registration of cases. The relative impact of each of theses factors is less clear because we don't have powerful statistical studies. Belgium is slightly above the European mean for breast cancer mortality, with 19,4/100.000 women/year and an all stages 15-year survival of 75%. Breast cancers are responsible for around 3% of all-cause mortality in Belgian women. This article discusses the causes of this high Belgian incidence and of current decrease of incidence in western countries, and reviews known and less known risk factors of breast cancers, with a special focus on menopause hormonal treatments.
Disciplines :
Oncologie
Auteur, co-auteur :
DESREUX, Joëlle ; Centre Hospitalier Universitaire de Liège - CHU > Sénologie
Gaspard, Ulysse ; Université de Liège - ULiège > Services généraux (Faculté de médecine) > Relations académiques et scientifiques (Médecine)
BLERET, Valerie ; Centre Hospitalier Universitaire de Liège - CHU > Sénologie
Van Cauwenberge, Jean-Rémy ; Université de Liège - ULiège > Département des sciences cliniques > Gynécologie-Obstétrique-Sénologie
THILLE, Alain ; Centre Hospitalier Universitaire de Liège - CHU > Imagerie médicale
HERMAN, Philippe ; Centre Hospitalier Universitaire de Liège - CHU > Sénologie
LIFRANGE, Eric ; Centre Hospitalier Universitaire de Liège - CHU > Sénologie
Langue du document :
Français
Titre :
Le cancer du sein en Belgique: pourquoi sommes-nous les premiers en Europe?
Titre traduit :
[en] Breast cancer in Belgium: why are we the first in Europe?
Date de publication/diffusion :
2011
Titre du périodique :
Revue Médicale de Liège
ISSN :
0370-629X
eISSN :
2566-1566
Maison d'édition :
Université de Liège. Revue Médicale de Liège, Liège, Belgique
Belgian Cancer Registry. - http://kankerregister.nettools.be/media/docs/ ib/large.html (23/05/11)
Soerjomataram I, de Vries E, Pukkala E, Coebergh JW. - Excess of cancers in Europe: A study of eleven major cancers amenable to lifestyle change. Int J Cancer, 2007, 120, 1336-1343.
Vandeloo MJ, Bruckers LM, Janssens JP. - Effects of lifestyle on the onset of puberty as determinant for breast cancer. Eur J Cancer Prev, 2007, 16, 17-25. (Pubitemid 46105004)
Hemminki K, Försti A, Sundquist J, Mousavi SM. - Preventable breast cancer is postmenopausal. Breast Cancer Res Treat, 2011, 125, 163-167.
Yue W, Santen RJ, Wang JP, et al. - Genotoxic metabolites of estradiol in breast : potential mechanism of estradiol induced carcinogenesis. J Steroid Biochem Mol Biol, 2003, 86, 477-486. (Pubitemid 37412587)
Singletary SE. - Rating the risk factors for breast cancer. Ann Surg, 2003, 237, 474-482. (Pubitemid 38176426)
Garmendia ML, Pereira A, Alvarado ME, Atalah E. - Relation between insulin resistance and breast cancer among Chilean women. Ann Epidemiol, 2007, 17, 403-409. (Pubitemid 46784023)
Lahmann PH, Friedenreich C, Schuit AJ, et al. - Physical activity and breast cancer risk : the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev, 2007, 16, 36-42. (Pubitemid 46174261)
Friedenreich CM, Orenstein MR. - Physical activity and cancer prevention : etiologic evidence and biological mechanisms. J Nutr, 2002, 132, 3456S-3464S. (Pubitemid 35315820)
Li CI, Chlebowski RT, Freiberg M, et al. - Alcohol consumption and risk of postmenopausal breast cancer by subtype : the women's health initiative observational Study. J Natl Cancer Inst, 2010, 22, 1422-1431.
Cottet V, Touvier M, Fournier A, et al. - Postmenopausal breast cancer risk and dietary patterns in the E3N-EPIC prospective cohort study. Am J Epidemiol, 2009, 170, 1257-1267.
Gammon MD, Fink BN, Steck SE, Wolff MS. - Soy intake and breast cancer : elucidation of an unanswered question. Br J Cancer, 2008, 98, 2-3.
Stuebe AM, Willett WC, Xue F, Michels KB. - Lactation and incidence of premenopausal breast cancer : a longitudinal study. Arch Intern Med, 2009, 169, 1364-1371.
Larsen SB, Olsen A, Lynch J, et al. - Socioeconomic position and lifestyle in relation to breast cancer incidence among postmenopausal women : prospective cohort study, Denmark, 1993-2006. Cancer Epidemiol, 2011, Jan 10.
Welsh J, Wietzke JA, Zinser GM, et al. - Impact of the vitamin D3 receptor on growth-regulatory pathways in mammary gland and breast cancer. J Steroid Biochem Mol Biol, 2002, 83, 85-92. (Pubitemid 37040644)
Manson JE, Mayne ST, Clinton SK. - Vitamin D and prevention of cancer ready for prime time? N Engl J Med, 2011, 364, 1385-1387.
Roddam AW, Pirie K, Pike MC, et al. - Active and passive smoking and the risk of breast cancer in women aged 36-45 years : a population based case-control study in the UK. Br J Cancer, 2007, 97, 434-439. (Pubitemid 47196735)
http://www.heartstats.org.uk/datapage.asp?id=4745
World Health Organization (2007) European Health for all statistical database.
Staessen L, De Henauw S, De Bacquer D, et al. - Consumption of fatty acids in Belgium and its relationship with cancer mortality. Cancer Lett, 1997, 114, 109-111. (Pubitemid 27140088)
Chajès V, Thiébaut AC, Rotival M, et al. - Association between rerum trans-monounsaturated fatty acids and breast cancer risk in the E3N-EPIC Study. Am J Epidemiol, 2008, 167, 1312-1320. (Pubitemid 351770558)
Engel P, Fagherazzi G, Mesrine S, et al. - Joint effects of dietary vitamin D and sun exposure on breast cancer risk : results from the French E3N cohort. Cancer Epidemiol Biomarkers Prev, 2011, 20, 187-198.
Hill C, rapport des académies françaises, 2007.
Collaborative Group on Hormonal Factors in Breast Cancer. - Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53.297 women with breast cancer and 100.239 women without breast cancer from 54 epidemiological studies. Lancet, 1996, 347, 1713-1727.
LaCroix AZ, Chlebowski RT, Manson JE, et al. - Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial. JAMA, 2011, 305, 1305-1314.
Schramek D, Leibbrandt A, Sigl V, et al. - Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer. Nature, 2010, 468, 98-104.
Lee SA, Ross RK, Pike MC. - An overview of menopausal estrogen-progestin hormone therapy and breast cancer risk. Br J Cancer, 2005, 92, 2049-2058. (Pubitemid 40897429)
Fournier A, Berrino F, Clavel-Chapelon F. - Unequal risks for breast cancer associated with different hormone replacement therapies : results from the E3N cohort study. Breast Cancer Res Treat, 2008, 107, 103-111. (Pubitemid 350179584)
Lyytinen H,Pukkala E, Ylikorkala O. - Breast cancer risk in postmenopausal women using estradiol-progestogen therapy. Obstet Gynecol, 2009, 113, 65-73.
Chlebowski R, Chen Z, Cauley J. - Oral bisphophonate use and breast cancer incidence in postmenopausal women. J Clin Oncol, 2010, 28, 3582-3590.
Tyrer J, Cuzick J. - www.ems-trials.org/riskevaluator/
Ravdin PM, Cronin KA, Howlader N, et al. - The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med, 2007, 356, 1670-1674. (Pubitemid 46631679)
Colditz GA. - Decline in breast cancer incidence due to removal of promotor : combination of estrogen plus progestin. Breast Cancer Research, 2007, 9, 108-110.
Glass AG, Lacey JV Jr, Carreon JD, Hoover RN. - Breast cancer incidence, 1980-2006 : combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst, 2007, 99, 1152-1161. (Pubitemid 47233065)
Vankrunkelsven P, Kellen E, Lousbergh D, et al. - Reduction in hormone replacement therapy use and declining breast cancer incidence in the Belgian province of Limburg. Breast Cancer Res Treat, 2009, 118, 425-432.
Chlebowski RT, Anderson GL, Gass M, et al. - Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. JAMA, 2010, 304, 1684-1692.
Charlier C, Albert A, Herman Ph, et al. - Breast cancer and serum levels of organochlorine residues. Occup Environ Med, 2003, 60, 348-351 . (Pubitemid 36532489)
Eliassen AH, Hankinson SE, Rosner B, et al. - Physical activity and risk of breast cancer among postmenopausal women. Arch Intern Med, 2010, 170, 1758-1764.
Kalager M, Zelen M, Langmark F, et al. - Effect of screening mammography on breast-cancer mortality in Norway. New Engl J Med, 2010, 363, 1203-1210.
